66 results
Page 2 of 4
424B3
3q5c d1w5h9kev9
7 Jul 21
Prospectus supplement
5:16pm
8-K
EX-99.2
157z125h2fa
8 Jun 21
Regulation FD Disclosure
2:01pm
8-K
EX-99.1
p6zp5j4m77iuboa90
8 Jun 21
Regulation FD Disclosure
2:01pm
424B5
yse21gu2y 5l1yibroid
23 Apr 21
Prospectus supplement for primary offering
4:05pm
8-K
EX-1.1
0ylmb91
22 Apr 21
NeuBase Therapeutics Announces Pricing of $40 Million Public Offering of Common Stock
9:33am
424B5
1o7e27tp qn9
21 Apr 21
Prospectus supplement for primary offering
4:03pm
8-K
EX-99.1
f0rda4
16 Dec 20
Regulation FD Disclosure
9:00am
8-K
EX-99.1
2ppugy8l
14 May 20
NeuBase Therapeutics Reports Financial Results for the Second Fiscal Quarter of 2020
4:06pm
424B5
bcaeqc298y99rk
29 Apr 20
Prospectus supplement for primary offering
4:21pm
424B5
d6p6wobniy94rn6 c70
27 Apr 20
Prospectus supplement for primary offering
4:23pm
8-K/A
EX-99.1
zlqldasa7z811h8xw
3 Apr 20
Financial Statements and Exhibits
5:10pm
8-K
EX-99.2
pd9 sd4k15vg
31 Mar 20
NeuBase Therapeutics Announces Positive, Preclinical Data Validating its Novel Genetic Therapy PATrOLâ„¢ Platform
9:10am